Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
Open Access
- 1 February 2013
- journal article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 19 (2) , E72-E79
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreakJournal of Antimicrobial Chemotherapy, 2012
- Rapid Detection of Carbapenemase-producingEnterobacteriaceaeEmerging Infectious Diseases, 2012
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination TherapyClinical Infectious Diseases, 2012
- Broad-Spectrum β-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due to Klebsiella pneumoniae Producing the Carbapenemase OXA-48Antimicrobial Agents and Chemotherapy, 2012
- Emergence of OXA-48-Type Carbapenemase-Producing Enterobacteriaceae in German HospitalsAntimicrobial Agents and Chemotherapy, 2012
- European dissemination of a single OXA-48-producing Klebsiella pneumoniae cloneClinical Microbiology and Infection, 2011
- OXA-163, an OXA-48-Related Class D β-Lactamase with Extended Activity Toward Expanded-Spectrum CephalosporinsAntimicrobial Agents and Chemotherapy, 2011
- Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in FranceAntimicrobial Agents and Chemotherapy, 2011
- Spread of OXA-48-Encoding Plasmid in Turkey and BeyondAntimicrobial Agents and Chemotherapy, 2010
- Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, TurkeyAntimicrobial Agents and Chemotherapy, 2008